Brellium Inc.
Category: AI in Healthcare
AI-powered clinical compliance platform that automates chart review for healthcare providers. Brellium Inc. was founded in 2023. The company is led by Zach Rosen. Based in New York, NY, USA. Team size: 41. Total funding raised: $11.1M. Latest round: $11.1M Venture Round / Series B (February 2024). Key investors include Bonfire Ventures, Operator Partners, PJC, Primary Venture Partners.
- Founded
- 2023
- Headquarters
- New York, NY, USA
- Team size
- 41
- Total funding
- $11.1M
Value proposition
Automates and instantly screens every patient visit against custom clinical and payer standards, ensuring compliance, accurate billing, and improved patient care.
Products and solutions
AI Automated Chart Review Platform, Clinical Compliance Audit Tools, EMR/PMS Integration Module
Unique value
Automates clinical and billing compliance audits by analyzing session notes with AI tuned to custom standards specific to healthcare compliance.
Target customer
Healthcare providers and clinics (ranging from small practices to large hospital networks).
Industries served
Healthcare (Providers, Clinics)
Technology advantage
Utilizes proprietary AI for interpreting clinical notes against stringent compliance rules with seamless, low-code integration into existing EMR/PMS systems.
How they differentiate
Focuses on automated, real-time compliance and billing accuracy within clinical notes, whereas competitors may have a broader focus on data extraction or analytics.
Main competitors
Fathom, Navina, Abstractive Health
Key partnerships
Partnerships with select EMR and PMS vendors (specific names not publicly disclosed)
Notable customers
Information not publicly disclosed for early-stage healthcare tech adoption.
Major milestones
Secured $11.1M in funding (Feb 2024) Launched AI chart review platform Developed EMR/PMS integration capabilities
Growth metrics
Not publicly disclosed.
Market positioning
Early-stage innovator in AI-driven clinical compliance automation for healthcare providers.
Geographic focus
Primarily the United States market.
Patents and IP
No publicly disclosed patents found.
About Zach Rosen
Zach Rosen is the Co-Founder and CEO of Brellium, an AI-powered clinical compliance platform. He co-founded the company in 2021 with the mission to improve the standard of care in the US healthcare system by helping clinics use data to ensure clinical and payer compliance. Prior to Brellium, Zach co-founded Sapien, a company focused on hospital and health system procurement. He has a background in business from the University of California, Berkeley.
Official website: https://brellium.com/